Blood test

The data has been concerning even before the release of the most recent report. With more than 6 million Americans currently diagnosed with dementia (that’s nearly 10% of people 65 and older), more than 100,000 deaths a year attributable to dementia, and more than $600 billion in annual dementia caregiving…

Not very long ago, we highlighted the advent of a new blood test to detect colon cancer. While we made clear its accuracy in detecting early-stage colon cancer is not equal to that of a traditional colonoscopy, for those who have not undergone a colonoscopy or other screening tests, it…

Not very long ago we brought you the news that a new blood test had been developed to test for colorectal (CRC) cancer. This past week, the FDA approved the test, called Shield, produced by the drug manufacturer Guardant. Endorsed by both the American Cancer Society and the US Preventive…

Just in time to raise awareness during National Colorectal Cancer Awareness Month, a new study in the New England Journal of Medicine reports that a blood test has now been developed to detect the presence of colorectal cancer, becoming another tool to identify what has been described as the second…

Last summer, we reported on the FDA approval of Leqembi, a medication that slows down cognitive decline in patients with Mild Cognitive Impairment or early Alzheimer’s Disease. While the medication is now covered by Medicare, patients who want access still have to demonstrate a diagnosis of Alzheimer’s and still have…

There are probably lots of good reasons for you to feel anxious these days. Maybe you’re experiencing health problems. Maybe you’re worried about your family or even the future of our country. Maybe you’re concerned about inflation and the endurance of your retirement savings (or maybe even the safety of…